Idexx Laboratories (IDXX) Net Cash Flow (2009 - 2026)

Idexx Laboratories' Net Cash Flow history runs 18 years deep, the most recent figure standing at $21.3 million for Q1 2026.

• In Q1 2026, Net Cash Flow rose 117.44% year-over-year to $21.3 million; the TTM figure through Mar 2026 stood at $23.8 million (up 110.57% YoY), while the FY2025 annual figure was -$119.4 million, up 23.53% from the prior year.
• Net Cash Flow for Q1 2026 stood at $21.3 million, up from -$28.1 million in the prior quarter.
• The five-year high for Net Cash Flow was $201.6 million in Q3 2023, with the low at -$122.0 million in Q1 2025.
• The 5-year median for Net Cash Flow is -$1.7 million (2023), against an average of $3.6 million.
• The sharpest annual moves came in 2022 and 2024: Net Cash Flow soared 7091.35% in 2022, then tumbled 3021.01% in 2024.
• Idexx Laboratories' Net Cash Flow stood at $7.5 million in 2022, then soared by 1472.03% to $117.6 million in 2023, then tumbled by 109.02% to -$10.6 million in 2024, then slumped by 164.83% to -$28.1 million in 2025, then soared by 175.78% to $21.3 million in 2026.
• Business Quant data shows IDXX's Net Cash Flow at $21.3 million in Q1 2026, -$28.1 million in Q4 2025, and $44.2 million in Q3 2025.